Implications of Heparin-Induced Thrombocytopenia Overdiagnosis

Annals of Pharmacotherapy

Volumn 48, Issue 10, 2014, Pages 1394-1395

  Smythe, Maureen A ^a,b   Koerber, John M ^a,b   Forsyth, Lisa L ^a,b   Tuchscherer, Rhianna M ^c  

^a BEAUMONT HOSPITAL   (United States)

^b WAYNE STATE UNIVERSITY   (United States)

^c UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; ARGATROBAN; HEPARIN; THROMBIN INHIBITOR; WARFARIN;

AGED; CASE REPORT; CONTINUOUS INFUSION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEMODIALYSIS; HEPARIN INDUCED THROMBOCYTOPENIA; HOSPITAL ADMISSION; HOSPITAL READMISSION; HUMAN; IMMUNOASSAY; INFORMATION TECHNOLOGY; LETTER; MENINGIOMA; PATIENT SAFETY; PRIORITY JOURNAL; THROMBOCYTE COUNT; THROMBOCYTOPENIA; CHEMICALLY INDUCED; DIAGNOSTIC ERROR; GASTROINTESTINAL HEMORRHAGE;

AGED; ANTICOAGULANTS; DIAGNOSTIC ERRORS; FEMALE; GASTROINTESTINAL HEMORRHAGE; HEPARIN; HUMANS; THROMBOCYTOPENIA;

EID: 84907362403     PISSN: 10600280     EISSN: 15426270     Source Type: Journal    
DOI: 10.1177/1060028014542462     Document Type: Letter

References (5)

1. Warkentin TE.Heparin-induced thrombocytopenia, pathogenesis and management.Br J Haematol. 2003;121:535-535.
2. Cuker A,Gimotty PA,Crowther MA,Warkentin TE.Predictive value of the 4Ts scoring system for heparin-induced thrombocytopenia; a systematic review and meta-analysis.Blood. 2012;120:4160-4167.
3. Warkentin TE,Sheppard JI,Moore JC,Sigouin CS,Kelton JG.Quantitative interpretation of optical density measurements using PF4-dependent enzyme-immunoassays.J Thromb Haemost. 2008;6:1304-1312.
4. Warkentin TE.HITlights: a career perspective on heparin-induced thrombocytopenia.Am J Hematol. 2012;87:s92-s99.
5. Smythe MA,Mehta TP,Koerber JM, et al.Development and implementation of a comprehensive heparin-induced thrombocytopenia recognition and management protocol.Am J Health Syst Pharm. 2012;69:241-248.